“bob-langer” Archives

in
Entry Author Date Location
Nominations Are Open for the 2019 Xconomy Awards in Boston 03/13/19 Boston
Seer Launches to Develop Liquid Biopsy for Cancer, Brain Disease 12/17/18 San Francisco
Xconomy Awards 2018 Gala Honors the Best of Boston Life Science: Slideshow 10/11/18 Boston
SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot 08/08/18 Boston
Lundbeck Reaches Across Atlantic, Picks Dunsire for CEO Post 07/02/18 Boston
Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More 04/06/18 National
Lilly Licenses Sigilon’s Cell Encapsulation Tech for Diabetes Therapy 04/04/18 Boston
Xconomy Awards—2018 Nominations Are Open 03/01/18 Boston
Xconomy Newcomer Award Winner Amy Schulman on Boston Biotech Life 11/06/17 Boston
Xconomy Young Innovator Award Winner Armon Sharei—CEO Before 30 10/23/17 Boston
MIT’s The Engine, Now With $200M, Makes First Bets: 3 Takeaways 09/19/17 Boston
Boston Is Arguably the Heart of Biotech. But Who Makes It So? Have Your Say. 06/26/17 Boston
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies 04/11/17 Boston
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Seventh Sense Gets Initial FDA Clearance for Simple Blood-Draw Device 02/23/17 Boston
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Frequency, Led by MIT’s Langer, Aims to Fight Hearing Loss With Drugs 01/05/17 Boston
Seventh Sense Biosystems Sucks In $10M for Simple Blood-Draw Device 11/18/16 Boston
MIT’s Bhatia Refocuses Spotlight on Gender Diversity in Biotech 09/12/16 Boston
Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More 08/26/16 National
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
Tarveda Formally Spins Out Placon to Advance Platinum Cancer Drugs 03/23/16 Boston
Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug 01/27/16 Boston
Biogen, Arsia Team Up to Improve Hemophilia Drugs in $100M Pact 12/16/15 Boston
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy 12/07/15 Boston
Taris 2.0: A Year After Buyout, VCs Bet $32M More on a Second Strike 10/27/15 Boston
SQZ Biotech Shifts to Therapy Development with $5M Series A 06/24/15 Boston
Where the Red Book Meets the Unicorn 06/22/15 Boston
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
Page 1 of 5 next page »